Report of Foreign Issuer (6-k)

---

---

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

______________________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of May 2014

 

Commission File Number: 001-36073

 

                   Enzymotec Ltd.                   

(Translation of registrant’s name into English)

 

Sagi 2000 Industrial Area

P.O. Box 6

 Migdal Ha’Emeq 2310001, Israel

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F  x                                            Form 40-F  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes  o                                            No  x

 

         If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):  82-________

 

 

 

---

 

 

EXPLANATORY NOTE

 

  Pursuant to the notice of an extraordinary general meeting of shareholders of Enzymotec Ltd. (the “ Company ”), which was attached as Exhibit 99.1 to the Company’s report of Foreign Private Issuer on Form 6-K furnished to the Securities and Exchange Commission on May 20, 2014, the Company hereby furnishes the following documents:

 

(i)

Notice and Proxy Statement with respect to the Company’s extraordinary general meeting of the shareholders describing proposal to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting; and

 

(ii)

a Proxy Card whereby holders of ordinary shares of the Company may vote at the meeting without attending in person.

 

  The Notice and Proxy Statement is attached to this Form 6-K as Exhibit 99.1 and the Proxy Card is attached to this Form 6-K as Exhibit 99.2

 

 

2

---

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	ENZYMOTEC LTD.
Date: May 30, 2014	By:	/s/ Oren Bryan
		Name: Oren Bryan
		Title:   Chief Financial Officer

                 

 

3

---

 

 

EXHIBIT INDEX

 

The following exhibit is filed as part of this Form 6-K:

 

Exhibit                      Description

 

99.1	Notice and Proxy Statement with respect to the Company’s Extraordinary General Meeting of the shareholders.

 

99.2	Proxy Card with respect to the Company’s Extraordinary General Meeting of the shareholders.

 

4

---

---